When was Vétoquinol founded?

Vétoquinol was founded in 1933 and raised its 1st funding round 87 years after it was founded.

Where is Vétoquinol located?

Vétoquinol is headquartered in Lure, France. It is registered at Walterovo náměstí 329 15800 Praha.

Who is the current CEO of Vétoquinol?

Etienne Frechin and Matthieu Frechin s of Vétoquinol.

How many employees does Vétoquinol have?

As of Aug 31, 2026, the latest employee count at Vétoquinol is 1609.

Is Vétoquinol a funded company?

Vétoquinol is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Dec 17, 2020.

When was the latest funding round of Vétoquinol?

Vétoquinol's latest funding was a $***** Grant (prize money) round on Dec 17, 2020, with participation from 1 investor.

Where does Vétoquinol rank among its competitors?

Vétoquinol ranks 4th amongst 60 active competitors, of which 13 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Loyal, which secured $100M in Feb, 2026.

Who are the top competitors of Vétoquinol?

Vétoquinol's top competitors include Loyal, Gallant and Anivive. Among them, Loyal secured the most recent funding round in February, 2026.

Vétoquinol - 2026 Company Profile, Team, Funding & Competitors

Vétoquinol is a public company based in Lure (France), founded in 1933. It operates as a Developer of therapeutics drugs for animal health. Vétoquinol has raised an undisclosed amount in funding. The company has 60 active competitors, including 13 funded and 5 that have exited. Its top competitors include companies like Loyal, Gallant and Anivive.

Company Details

Vetoquinol is developing therapeutics drugs for animal health. The company is developing the formulation such as long-acting injectable formulas with a single administration, practical for injecting antibiotics into a herd, appetizing tablets that can be taken spontaneously by dogs and cats among others.

Website: www.vetoquinol.com/en
Social
Email ID: *****@vetoquinol.com
Phone Number: +33 **********
Registered Address: Walterovo náměstí 329 15800 Praha

Key Metrics

Founded Year

1933

Location

Lure, France

Stage

Public

Latest Funding Round

Grant (prize money), Dec 17, 2020, $*****

Investors

Economy And Finance & 1 more

Ranked

4^th among 60 active competitors

Employee Count

1,609 as on Aug 31, 2026

Investment & Acquisitions

Plant Advanced Technologies & 1 more

Similar Companies

Loyal & 43 more

Exit Details

Public

View Vétoquinol's full profile

Vétoquinol is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Vetoquinol s.r.o. CIN: 25634194 , Czech Republic, Active	Dec 22, 1997	-	-

Vétoquinol got listed on Nov 16, 2006.

Click here to take a look at Vétoquinol's IPO in detail

Vétoquinol has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Dec 17, 2020 for $*****. 1 investor participated in its latest round. Vétoquinol has 2 institutional investors.

Here is the list of recent funding rounds of Vétoquinol:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 17, 2020	9706246	Grant (prize money)	3832235	4455886	8336931	5709000

Access funding benchmarks and valuations. Sign up today!

View details of Vétoquinol's funding rounds and investors

Vétoquinol's employee count trend

Vétoquinol has 1,609 employees as of Aug 26. Here is Vétoquinol's employee count trend over the years:

Uncover Vétoquinol's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vétoquinol include Loyal, Gallant and Anivive. Here is the list of Top 10 competitors of Vétoquinol, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Loyal 2020, San Francisco (United States), Series C	Provider of therapeutics for the treatment of dogs health	$250M	Khosla Ventures, Collab Fund & 17 others	58/100
2nd	Gallant 2018, Los Angeles (United States), Series B	Provider of stem cell based regenerative therapy for dogs	$61.5M	Bold Capital Partners, Digitalis Ventures ... & 13 others	55/100
3rd	Anivive 2015, Long Beach (United States), Series C	Developer of therapeutics for animals	$44.3M	LEONID, FDA & 1 others	55/100
4th	Vétoquinol 1933, Lure (France), Public	Developer of therapeutics drugs for animal health	-	Economy And Finance, Azulis Capital	53/100
5th	Bioceltix 2017, Wroclaw (Poland), Seed	Developer of drugs for veterinary therapy	-	Infini, Leonarto	48/100
6th	Invetx 2018, Boston (United States), Acquired	Provider of pharmaceutical products like protein-based therapeutics for pets	$86M	F-Prime Capital, Novo Holdings & 7 others	45/100
7th	ZYMOX 1999, Westmont (United States), Unfunded	Provider of enzyme-based pet care and therapeutics products	-	-	45/100
8th	VetStem 2002, Poway (United States), Unfunded	Developer of vet stem cell therapy for animal health	-	-	43/100
9th	Felixvet 2014, Dublin (Ireland), Late Stage	Manufacturer of generic and complex veterinary pharmaceuticals for companion animals	-	Advent International	40/100
10th	eQcell 2010, Guelph (Canada), Series A	Developer of stem cell therapies for the treatment of animals	$4.6M	Accelerator Centre, Ag Capital Canada	37/100